Plus Therapeutics Inc’s filing revealed that its Director Hawkins Richard J acquired Company’s shares for reported $5996.0 on Sep 13 ’24. In the deal valued at $1.50 per share,4,000 shares were bought. As a result of this transaction, Hawkins Richard J now holds 15,188 shares worth roughly $11998.52.
Then, Hawkins Richard J bought 6,285 shares, generating $8,512 in total proceeds. Upon buying the shares at $1.35, the Director now owns 11,188 shares.
Before that, Petersen Greg bought 12,500 shares. Plus Therapeutics Inc shares valued at $16,875 were divested by the Director at a price of $1.35 per share. As a result of the transaction, Petersen Greg now holds 48,921 shares, worth roughly $38647.590000000004.
D. Boral Capital initiated its Plus Therapeutics Inc [PSTV] rating to a Buy in a research note published on March 17, 2025; the price target was $9. A number of analysts have revised their coverage, including Ladenburg Thalmann’s analysts, who began to cover the stock in late January with a ‘”a Buy”‘ rating. Maxim Group began covering PSTV with “Buy” recommendation on October 16, 2020.
Price Performance Review of PSTV
On Tuesday, Plus Therapeutics Inc [NASDAQ:PSTV] saw its stock jump 22.78% to $0.79. Over the last five days, the stock has gained 23.06%. Plus Therapeutics Inc shares have fallen nearly -31.57% since the year began. Nevertheless, the stocks have fallen -53.47% over the past one year. While a 52-week high of $2.67 was reached on 03/07/25, a 52-week low of $0.24 was recorded on 03/04/25. SMA at 50 days reached $0.9649, while 200 days put it at $1.2853.
Levels Of Support And Resistance For PSTV Stock
The 24-hour chart illustrates a support level at 0.6151, which if violated will result in even more drops to 0.4433. On the upside, there is a resistance level at 0.9544. A further resistance level may holdings at 1.1219. The Relative Strength Index (RSI) on the 14-day chart is 47.25, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0550, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 53.42%. Stochastics %K at 20.72% indicates the stock is a holding.
How much short interest is there in Plus Therapeutics Inc?
A steep rise in short interest was recorded in Plus Therapeutics Inc stocks on 2025-03-31, growing by 1.11 million shares to a total of 1.25 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 0.14 million shares. There was a rise of 88.78%, which implies that there is a positive sentiment for the stock.
